https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(23)00020-2/fulltext
0
0
Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial - The Lancet
2/3/23 at 11:34pm
Organization
The Lancet
Authors
Details
62 words
Summarize
Health Conditions Health Methylprednisolone The Lancet methylprednisolone RCT anti-SARS-CoV-2 MIS-C
In this RCT, treatment with methylprednisolone in children with PIMS-TS did not significantly affect the length of hospital stay compared with intravenous immunoglobulins. Intravenous methylprednisolone could be an acceptable first-line treatment in children …
Create an account or login to join the discussion